相似文献
1
Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination.
J Bacteriol. 2009 Feb;191(3):1115-7. doi: 10.1128/JB.01260-08. Epub 2008 Dec 5.
2
Bile salts and glycine as cogerminants for Clostridium difficile spores.
J Bacteriol. 2008 Apr;190(7):2505-12. doi: 10.1128/JB.01765-07. Epub 2008 Feb 1.
3
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.
J Bacteriol. 2010 Oct;192(19):4983-90. doi: 10.1128/JB.00610-10. Epub 2010 Jul 30.
4
Mapping interactions between germinants and Clostridium difficile spores.
J Bacteriol. 2011 Jan;193(1):274-82. doi: 10.1128/JB.00980-10. Epub 2010 Oct 22.
5
Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts.
PLoS One. 2012;7(2):e32381. doi: 10.1371/journal.pone.0032381. Epub 2012 Feb 22.
6
Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor.
J Bacteriol. 2015 Dec 14;198(5):777-86. doi: 10.1128/JB.00908-15.
7
Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores.
J Bacteriol. 2010 Aug;192(16):4215-22. doi: 10.1128/JB.00488-10. Epub 2010 Jun 18.
8
Physical and chemical factors influencing the germination of Clostridium difficile spores.
J Appl Microbiol. 2008 Dec;105(6):2223-30. doi: 10.1111/j.1365-2672.2008.03965.x.
9
Mechanism of germination inhibition of Clostridioides difficile spores by an aniline substituted cholate derivative (CaPA).
J Antibiot (Tokyo). 2023 Jun;76(6):335-345. doi: 10.1038/s41429-023-00612-3. Epub 2023 Apr 4.
10
Fate of ingested Clostridium difficile spores in mice.
PLoS One. 2013 Aug 30;8(8):e72620. doi: 10.1371/journal.pone.0072620. eCollection 2013.
引用本文的文献
1
The Pxp Complex Detoxifies 5-Oxoproline and Promotes the Growth of Clostridioides difficile.
Mol Microbiol. 2025 Jul;124(1):66-76. doi: 10.1111/mmi.15373. Epub 2025 May 8.
2
Bile acids as germinants for Clostridioides difficile spores, evidence of adaptation to the gut?
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf005.
3
colonization is not mediated by bile salts and utilizes Stickland fermentation of proline in an model.
mSphere. 2025 Feb 25;10(2):e0104924. doi: 10.1128/msphere.01049-24. Epub 2025 Jan 16.
4
Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease.
Curr Res Microb Sci. 2024 Nov 17;7:100315. doi: 10.1016/j.crmicr.2024.100315. eCollection 2024.
5
Comparative effectiveness of treatments for recurrent infection: a network meta-analysis of randomized controlled trials.
Front Pharmacol. 2024 Oct 17;15:1430724. doi: 10.3389/fphar.2024.1430724. eCollection 2024.
6
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of infection in adults.
SAGE Open Med. 2024 Oct 9;12:20503121241274192. doi: 10.1177/20503121241274192. eCollection 2024.
7
Gut Microbial and Metabolic Features Associated With Infection Recurrence in Children.
Open Forum Infect Dis. 2024 Sep 3;11(9):ofae506. doi: 10.1093/ofid/ofae506. eCollection 2024 Sep.
8
The Impact of YabG Mutations on Clostridioides difficile Spore Germination and Processing of Spore Substrates.
Mol Microbiol. 2024 Oct;122(4):534-548. doi: 10.1111/mmi.15316. Epub 2024 Sep 11.
9
colonization is not mediated by bile salts and utilizes Stickland fermentation of proline in an model.
bioRxiv. 2024 Dec 11:2024.07.17.603937. doi: 10.1101/2024.07.17.603937.
10
The impact of YabG mutations on spore germination and processing of spore substrates.
bioRxiv. 2024 Jun 10:2024.06.10.598338. doi: 10.1101/2024.06.10.598338.
本文引用的文献
1
Bile salts and glycine as cogerminants for Clostridium difficile spores.
J Bacteriol. 2008 Apr;190(7):2505-12. doi: 10.1128/JB.01765-07. Epub 2008 Feb 1.
2
Treatment of Clostridium difficile infection.
Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S32-42. doi: 10.1086/521860.
3
Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?
Antimicrob Agents Chemother. 2007 Aug;51(8):2883-7. doi: 10.1128/AAC.01443-06. Epub 2007 Jun 11.
4
Human cecal bile acids: concentration and spectrum.
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G256-63. doi: 10.1152/ajpgi.00027.2007. Epub 2007 Apr 5.
5
Identification of an in vivo inhibitor of Bacillus anthracis spore germination.
J Biol Chem. 2007 Apr 20;282(16):12112-8. doi: 10.1074/jbc.M611432200. Epub 2007 Feb 12.
6
Bile salt biotransformations by human intestinal bacteria.
J Lipid Res. 2006 Feb;47(2):241-59. doi: 10.1194/jlr.R500013-JLR200. Epub 2005 Nov 18.
7
Clostridium difficile toxins: mechanism of action and role in disease.
Clin Microbiol Rev. 2005 Apr;18(2):247-63. doi: 10.1128/CMR.18.2.247-263.2005.
8
Spore germination.
Curr Opin Microbiol. 2003 Dec;6(6):550-6. doi: 10.1016/j.mib.2003.10.001.
9
Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples.
Gut. 2001 Dec;49(6):835-42. doi: 10.1136/gut.49.6.835.
10
Antibiotics and Clostridium difficile.
Microbes Infect. 1999 Apr;1(5):377-84. doi: 10.1016/s1286-4579(99)80054-9.
Zotero 插件